Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ashland ( (ASH) ) has shared an announcement.
Ashland reported a challenging first quarter for fiscal year 2025, with sales down 14% compared to the previous year, primarily due to its portfolio optimization initiatives. These initiatives, which involved divesting certain product lines, reduced sales by about $50 million, impacting financial metrics like adjusted EBITDA and net income. The company also signed an agreement to sell its Avoca business and is executing a $30 million cost reduction plan to offset losses. Despite market challenges, Ashland is focused on advancing its global business lines and new technology platforms, while navigating economic uncertainties and trade policy changes under the new U.S. administration.
More about Ashland
Ashland Inc. is a global company specializing in additives and specialty ingredients with leadership positions in consumer-focused markets such as pharmaceuticals, personal care, and architectural coatings.
YTD Price Performance: 2.01%
Average Trading Volume: 464,523
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.35B
For an in-depth examination of ASH stock, go to TipRanks’ Stock Analysis page.
